Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on August 27, 2025

Dr. Francisco M. Torres, M.D. Selected as a Recipient of the Castle Connolly Top Doctors 2025 Award

Dr. Francisco M. Torres, M.D. Selected as a Recipient of the Castle Connolly Top Doctors 2025 Award

Clearwater, Florida – We are proud to announce that Dr. Francisco M. Torres, M.D., has been honored with the Castle Connolly Top Doctors 2025 Award. CLEARWATER, FL, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- We are proud to announce that Dr. …

ATIV Software Launches EventPilot® AI Assistant to Navigate STM Conferences

ATIV Software Launches EventPilot® AI Assistant to Navigate STM Conferences

AI concierge improves attendee experience at complex scientific and medical meetings BRANDON, FL, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- ATIV Software, a leader in conference technology for scientific and medical meetings, today announced …

Bonmente Expands Footprint to Florida, Bringing Innovative Mental Health Services to the Sunshine State

Bonmente Expands Footprint to Florida, Bringing Innovative Mental Health Services to the Sunshine State

Bonmente's convenient, compassionate virtual psychiatric care services will help bridge the state’s critical mental health access gap MIAMI, FL, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- Bonmente, a leading provider of technology-enabled …

Collis Curve Finds New Strategies for Success with FEDCON

Collis Curve Finds New Strategies for Success with FEDCON

FEDCON's expert guidance along with its targeted outreach has made Collis Curve an attractive supplier during its initial three months of engagement TAMPA, FL, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- The company FederalGovernment.info ( …

Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, …

Tarsus to Participate in Upcoming Investor Conferences

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: Wells Fargo 20th Annual Healthcare Conference on Wednesday, …

Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering

Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering

Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, …

Jasper Therapeutics to Present at Upcoming Investor Conferences

Jasper Therapeutics to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell …

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the …

Supernus Pharmaceuticals to Participate in September Investor Conferences

Supernus Pharmaceuticals to Participate in September Investor Conferences

ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today …

CooperCompanies Announces Third Quarter 2025 Results

CooperCompanies Announces Third Quarter 2025 Results

SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 …

Anaptys Announces Participation in September Investor Conferences

Anaptys Announces Participation in September Investor Conferences

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of …

Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering

Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering

WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an underwritten public offering of 1,750,000 shares of common …

Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025

Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025

AURORA, Colo., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (“Bespoke” or the “Company”) (OTCQB: BSPK), today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in September

Aardvark Therapeutics to Present at Upcoming Investor Conferences in September

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …

Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico

Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico

MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to …

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

MannKind to Present at Upcoming Investor Conferences

MannKind to Present at Upcoming Investor Conferences

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with …

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions